港股異動丨赤子城科技(9911.HK)飆漲23%創6個月新高 旗下MICO上榜海外收入前十
格隆匯7月6日丨赤子城科技(09911.HK)午後漲幅擴大至23%,報2.78港元創6個月新高,暫成交8391萬港元,最新總市值27.8億港元。赤子城科技旗下全球開放式社交平台MICO登上海外下載榜TOP20,並再度闖入收入榜TOP10,排名第6。 據瞭解,MICO於2014年開始出海,是國內最早出海的社交平台之一。現階段,MICO已在東南亞、中東、印度、北美等市場深入佈局,並積極拓展歐洲、日韓、俄語區等市場,積累了全球150餘個國家和地區的超1億用户。2017年-2019年,MICO收入的複合增長率高達157.63%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.